DCEBIO stimulates Cl- secretion in the mouse jejunum

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 1, 2006, Pages

  Hamilton, Kirk L ^a   Kiessling, Matt ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

1 ethyl 2 benzimidazolinone; Clotrimazole; Forskolin; Glibenclamide; H89

Indexed keywords

5,6 DICHLORO 1 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; BENZIMIDAZOLE DERIVATIVE; BUMETANIDE; CHLORIDE ION; CLOTRIMAZOLE; FORSKOLIN; GLIBENCLAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; UNCLASSIFIED DRUG; 1 ETHYL 2 BENZIMIDAZOLINONE; 1-ETHYL-2-BENZIMIDAZOLINONE; 5,6-DICHLORO-1-ETHYL-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE; CALCIUM CHANNEL STIMULATING AGENT; CHLORIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; JEJUNUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH SECRETION; ANIMAL; METABOLISM; SECRETION;

ANIMALIA;

ANIMALS; BENZIMIDAZOLES; CALCIUM CHANNEL AGONISTS; CHLORIDES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FORSKOLIN; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; JEJUNUM; MALE; MICE;

EID: 33644825441     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00187.2005     Document Type: Article

References (74)

1. Al-Nakkash L, Hu S, Li M, and Hwang TC. A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs. J Pharmacol Exp Ther 296: 464-472, 2001.
2. Ameen N, Alexis J, and Salas P. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem Cell Biol 114: 69-75, 2000.
3. 2+-activated, intermediate conductance potassium channel. J Biol Chem 277: 3793-3800, 2002.
4. - secretion in the mouse jejunum. Am J Physiol Cell Physiol 287: C1636-C1645, 2004.
5. + and nonselective cation channels in the basolateral membrane of rat colonic crypt base cells. Pflügers Arch 432: 1011-1022, 1996.
6. Butt AG, Bowler JM, and McLaughlin C. Villus and crypt cell composition in the secreting mouse jejunum measured with x-ray microanalysis. J Membr Biol 162: 17-29, 1998.
7. Butt AG and Hamilton KL. Ion channels in isolated mouse jejunal crypts. Pflügers Arch 435: 528-538, 1998.
8. Chang EB and Rao MC. Intestinal water and electrolyte transport-mechanisms of physiological and adaptive responses. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR. New York: Raven, 1994, vols. 1 and 2, p. 2027-2081.
9. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, and Boucher RC. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 257: 1125-1128, 1992.
10. -/- mice. Proc Natl Acad Sci USA 91: 479-483, 1994.
11. Cuthbert AW. Assessment of CFTR chloride channel openers in intact normal and cystic fibrosis murine epithelia. Br J Pharmacol 132: 659-668, 2001.
12. + channels in murine colonic epithelia by 1-ethyl-2-benzimidazolone. Am J Physiol Cell Physiol 277: C111-C120, 1999.
13. Derand R, Bulteau-Pignoux L, and Becq F. Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: Effect of the benzimidazolone derivative NS004. J Membr Biol 194: 109-117, 2003.
14. K. Am J Physiol Lung Cell Mol Physiol 271: L785-L795, 1996.
15. + channel. Am J Physiol Lung Cell Mol Physiol 271: L775-L784, 1996.
16. + channels. Am J Physiol Cell Physiol 273: C531-C540, 1997.
17. Devor DC, Singh AK, Lambert LC, DeLuca A, Frizzell RA, and Bridges RJ. Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol 113: 743-760, 1999.
18. Dray X, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, and Hubert D. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin Gastroenterol Hepatol 2: 498-503, 2004.
19. - channels by protein kinases A and C. Pflügers Arch 444: 251-262, 2002.
20. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111: 931-943, 2003.
21. Field M. Ion transport in rabbit ileal mucosa. II. Effects of cyclic 3′,5′-AMP. Am J Physiol 221: 992-997, 1971.
22. 12 myoblasts and is downregulated during myogenesis. Am J Physiol Cell Physiol 289: C89-C96, 2005.
23. Fryklund J, Mattsson JP, Berglund ML, Helander HF, and Larsson H. Effects of chloride transport inhibitors on intestinal fluid and ion transport in vivo and in vitro. Acta Physiol Scand 149: 365-376, 1993.
24. Greger R, Bleich M, Leipziger J, Ecke D, Mall M, and Kunzelmann K. Regulation of ion transport in colonic crypts. News Physiol Sci 12: 62-66, 1997.
25. Gribkoff VK, Champigny G, Barbry P, Dworetzky SI, Meanwell NA, and Lazdunski M. The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel. J Biol Chem 269: 10983-10986, 1994.
26. Grubb BR. Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 268: G505-G513, 1995.
27. Grubb BR, Paradiso AM, and Boucher RC. Anomalies in ion transport in CF mouse tracheal epithelium. Am J Physiol Cell Physiol 267: C293-C300, 1994.
28. - secretion in the mouse jejunum. Exp Physiol 87: 437-445, 2002.
29. + channel in the mouse jejunum. Pflügers Arch 439: 158-166, 1999.
30. Hidaka H and Kobayashi R. Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32: 377-397, 1992.
31. 2+ stores by activation of ryanodine receptors in pancreatic B-cells. J Biol Chem 274: 14147-14156, 1999.
32. Hubel KA. The effects of electrical field stimulation and tetrodotoxin on ion transport by the isolated rabbit ileum. J Clin Invest 62: 1039-1047, 1978.
33. Ito Y, Son M, Sato S, Ohashi T, Kondo M, Shimokata K, and Kume H. Effects of fluoranthene, a polycyclic aromatic hydrocarbon, on cAMP-dependent anion secretion in human airway epithelia. J Pharmacol Exp Ther 308: 651-657, 2004.
34. + channel. Am J Physiol Cell Physiol 275: C848-C856, 1998.
35. + channel of intermediate conductance: a molecular target for novel treatments? Curr Drug Targets 2: 401-422, 2001.
36. + channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT keratinocytes. Inverse effects on cell growth and proliferation. J Biol Chem 278: 3323-3330, 2003.
37. Kunzelmann K and Mall M. Pharmacotherapy of the ion transport defect in cystic fibrosis. Clin Exp Pharmacol Physiol 28: 857-867, 2001.
38. Lai HC, Kosorok MR, Laxova A, Davis LA, FitzSimmon SC, and Farrell PM. Nutritional status of patients with cystic fibrosis with meconium ileus: A comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 105: 53-61, 2000.
39. - secretion in murine nasal and colonic epithelia. J Physiol 510: 237-247, 1998.
40. MacVinish LJ, Keogh J, and Cuthbert AW. EBIO, an agent causing maintained epithelial chloride secretion by co-ordinate actions at both apical and basolateral membranes. Pflügers Arch 443, Suppl 1: S127-S131, 2001.
41. 2+ interactions affecting epithelial chloride secretion in human cultured colonic epithelia. Br J Pharmacol 108: 462-468, 1993.
42. + channel (ENaC) in fetal rat alveolar type II epithelium. Biochem Pharmacol 66: 1083-1089, 2003.
43. O'Byrne P and Postma D. The many facets of airway inflammation. Asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: S41-S66, 1999.
44. O'Grady SM, Palfrey HC, and Field M. Characterisation and functions of Na-K-Cl cotransport in epithelial tissues. Am J Physiol Cell Physiol 253: C177-C192, 1987.
45. 3H]bumetanide binding and effects of furosemide analogues. J Membr Biol 96: 11-18, 1987.
46. O'Loughlin EV, Hunt DM, Gaskin KJ, Stiel D, Bruzuszcak IM, Martin HC, Bambach C, and Smith R. Abnormal epithelial transport in cystic fibrosis jejunum. Am J Physiol Gastrointest Liver Physiol 260: G758-G763, 1991.
47. + channels by novel benzimidazolone. Eur J Pharmacol 251: 53-59, 1994.
48. + channels in cerebellar granule cells. Neuroreport 5: 1001-1004, 1994.
49. Park RW and Grand RJ. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology 81: 1143-1161, 1981.
50. Pilewski JM and Frizzell RA. Role of CFTR in airway disease. Physiol Rev 79: S215-S255, 1999.
51. Ratjen F and Doring G. Cystic fibrosis. Lancet 361: 681-689, 2003.
52. Rescorla FJ and Grosfeld JL. Contemporary management of meconium ileus. World J Surg 17: 318-325, 1993.
53. Reuss L. Epithelial transport. In: Handbook of Physiology. Cell Physiology. Bethesda, MD: Am. Physiol. Soc., 1997, sect. 14, chapt 8, p. 309-388.
54. Riordan JR, Rommens JR, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, and Tsui LC. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073, 1989.
55. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, and Collins FS. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065, 1989.
56. Roomans G. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis. Am J Resp Med 2: 413-431, 2003.
57. - secretion by polarized monolayers of human colonic epithelial cells. J Clin Invest 98: 2066-2075, 1996.
58. + conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. J Clin Invest 100: 3111-3120, 1997.
59. Schultz BD, Deroos ADG, Venglarik CJ, Singh AK, Frizzell RA, and Bridges RJ. Glibenclamide blockade of CFTR chloride channels. Am J Physiol Lung Cell Mol Physiol 271: L192-L200, 1996.
60. - secretion. J Physiol 505: 411-423, 1997.
61. - channels expressed in murine cell line. J Physiol 503: 333-346, 1997.
62. Singh S, Syme CA, Singh AK, Devor DC, and Bridges RJ. Benzimidazolone activators of chloride secretion: Potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 296: 600-611, 2001.
63. + channel, hIK1, is dependent upon a C-terminal leucine zipper. J Biol Chem 278: 8476-8486, 2003.
64. Tamada T, Hug MJ, Frizzell RA, and Bridges RJ. Microelectrode and impedance analysis of anion secretion in Calu-3 cells. J Pancr 2: 219-228, 2001.
65. Taylor CJ, Baxter PS, Hardcastle J, and Hardcastle PT. Failure to induce secretion in jejunal biopsies from children with cystic fibrosis. Gut 29: 957-962, 1988.
66. + conductance in the rabbit conjunctival epithelium. Exp Eye Res 70: 295-305, 2000.
67. + channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem 273: 21542-21553, 1998.
68. + channels. Biochim Biophys Acta 1464: 69-82, 2000.
69. + channels in the intestinal epithelium. J Membr Biol 193: 67-78, 2003.
70. + channel (rSK4) of colonic crypts. Pflügers Arch 438: 437-444, 1999.
71. Welsh MJ. Cystic fibrosis. In: Molecular Biology of Membrane Transport Disorders, edited by Schultz SG, Andreoli TE, Brown AM, Fambrough DM, Hoffman JF, and Welsh MJ. New York: Plenum, 1996, p. 605-623.
72. Welsh MJ, Smith PL, Fromm M, and Frizzell RA. Crypts are the site of intestinal fluid and electrolyte secretion. Science 218: 1219-1221, 1982.
73. Wulff H, Gutman GA, Cahalan MD, and Chandy KG. Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem 276: 32040-32045, 2001.
74. Zhang ZR, Zeltwanger S, and McCarty NA. Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes. J Membr Biol 175: 35-52, 2000.